Funded startups/Solstice Oncology, Inc.

Solstice Oncology, Inc.

SEC filing

Biotechnology · Boston, MA

Form D on EDGAR

Amount raised$121.3Msold at filing

Total offering$298.4M$177.1M still open

Investors in the raise8count reported to the SEC

FiledMar 9, 2026first sale Feb 20, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

David FeltquateExecutive Officer

ANDREW LEVINDirector

JULIE GRANTDirector

EMILY MINKOWDirector

MORGAN HALLERDirector

Maiken Keson-BrookesExecutive Officer

CAROLINE LOEWExecutive Officer, Director, Promoter

Executive officers, directors and promoters as listed on the Form D.